prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. Unit in charge: I. Material collected on: I. aterial received on: Expected time of examination: up to 8 working days. Clinical diagnosis: Macroscopic description: Right breast Sized 20 x 14 x 5 cm removed along with axillary tissues sized 10 x 5 x 3 cm and a skin flap of 18 x 10 cm. Tumour. found in the upper outer quadrant, located 3 cm from the upper boundary, 1 cm from the base and 1.5 cm from the skin. Microscopic description: Carcinoma ductale invasivum NHG3 (3+3+3: 20 mitoses/10 HPF - visual area: 0.55mm). Invasio carcinomatosa vasorum massiva. Mamilla sine laesionibus. Glandular tissue showing mastopathia fibrosa. Axillary lymph nodes: Metastases carcinomatosae in lymphonodis (No V/ VIII). Infiltratio telae perinodalis. Emboliae carcinomatosae vasorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. Metastases carcinomatosae in lymphonodis axillae (No V / VIII). Cancer metastases in axillary lymph nodes (No V/VIII). (NHG3, pT2, pN2a). Invasio carcinomatosa vasorum massiva. Massive vascular invasion. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody. Score=2+, FISZ verification recommended. UDD:E8D4229D-5849-4991-BDE@-AFC2C8C1827E. Examination: Histopathological examination. I. Gender: F. Result of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND. Supplementary information: Size of the tumour 3.5 x 2.5 x 2.0 cm.

expanded version (tokens=955) : 
 The breast pathology report indicates the following information:

- Histological classification: Carcinoma ductale invasivum NHG3 (3+3+3: 20 mitoses/10 HPF - visual area: 0.55mm). Invasive ductal carcinoma of the right breast. Metastases carcinomatosae in lymphonodis axillae (No V / VIII). (NHG3, pT2, pN2a)
- Subtype: Luminal B
- Necrosis: No mention of necrosis
- Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes
- Histological grade: NHG3
- Nuclear grade: 3+3+3
- Lymphovascular invasion: Invasio carcinomatosa vasorum massiva. Massive vascular invasion.
- Calcification: No mention of calcification
- Receptor status: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei.
- IHC and ancillary testing results: HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody. Score=2+, FISH verification recommended​. HER-2 GENE AMPLIFICATION NOT FOUND with the FISH method by Path Vysion HER2 DNA Probe Kit. 

Additional information: 

- Clinical diagnosis: Not

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1112) : 
 Report: The breast pathology report shows the presence of invasive ductal carcinoma of the right breast with metastases in axillary lymph nodes. It has a histological grade of NHG3 with massive vascular invasion and a luminal B subtype. Results indicate estrogen and progesterone receptors present in over 75% of neoplastic cells, while HER-2 gene amplification is not found. Further FISH verification is required for HER2 protein staining. No mention of calcification or tumor-infiltrating lymphocytes is made in the report.

